Bristol-Myers Squibb Company Long Term Debt 2007–2025

Total Assets Cash on Hand Long Term Debt Total Liabilities Shareholder Equity

Bristol-Myers Squibb Company annual/quarterly long term debt history from 2008 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

Bristol-Myers Squibb Company long term debt for the quarter ending December 31, 2025 were 44.83B, a 9.31% decrease year-over-year.
Bristol-Myers Squibb Company long term debt for 2025 were 44.83B, a 9.31% decrease from 2024.
Bristol-Myers Squibb Company long term debt for 2024 were 49.43B, a 25.06% increase from 2023.
Bristol-Myers Squibb Company long term debt for 2023 were 39.53B, a 1.47% increase from 2022.
Bristol-Myers Squibb Company long term debt for 2022 were 38.95B.

Long Term Debt

QUARTERLY · $B

YOY QUARTERLY GROWTH · %

Bristol-Myers Squibb Company Annual Long Term Debt (Millions of US $)
2025	$44,827
2024	$49,431
2023	$39,526
2022	$38,953
2021	$44,369
2020	$50,336
2019	$46,150
2018	$6,895
2017	$6,975
2016	$5,716
2015	$6,550
2014	$7,242
2013	$7,981
2012	$7,232
2011	$5,376

Bristol-Myers Squibb Company Quarterly Long Term Debt (Millions of US $)
2025-12-31	$44,827
2024-12-31	$49,431
2023-12-31	$39,526
2022-12-31	$38,953
2021-12-31	$44,369
2020-12-31	$50,336
2019-12-31	$46,150
2018-12-31	$6,895
2017-12-31	$6,975
2016-12-31	$5,716
2015-12-31	$6,550
2014-12-31	$7,242
2013-12-31	$7,981
2012-12-31	$7,232
2011-12-31	$5,376
2010-12-31	$5,328
2009-12-31	$6,130
2008-12-31	$6,585

Bristol-Myers Squibb Company Long Term Debt — FAQ

Bristol-Myers Squibb Company (BMY) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BMY's long term debt history?

The chart and table above show Bristol-Myers Squibb Company's long term debt by year and by quarter, including the growth rate.